These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 26901756

  • 1. Hyaluronic acid modified mesoporous carbon nanoparticles for targeted drug delivery to CD44-overexpressing cancer cells.
    Wan L, Jiao J, Cui Y, Guo J, Han N, Di D, Chang D, Wang P, Jiang T, Wang S.
    Nanotechnology; 2016 Apr 01; 27(13):135102. PubMed ID: 26901756
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
    Zhong Y, Zhang J, Cheng R, Deng C, Meng F, Xie F, Zhong Z.
    J Control Release; 2015 May 10; 205():144-54. PubMed ID: 25596560
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hyaluronic acid modified mesoporous silica nanoparticles for targeted drug delivery to CD44-overexpressing cancer cells.
    Yu M, Jambhrunkar S, Thorn P, Chen J, Gu W, Yu C.
    Nanoscale; 2013 Jan 07; 5(1):178-83. PubMed ID: 23076766
    [Abstract] [Full Text] [Related]

  • 6. Fluorescent carbon dot-gated multifunctional mesoporous silica nanocarriers for redox/enzyme dual-responsive targeted and controlled drug delivery and real-time bioimaging.
    Wang Y, Cui Y, Zhao Y, He B, Shi X, Di D, Zhang Q, Wang S.
    Eur J Pharm Biopharm; 2017 Aug 07; 117():105-115. PubMed ID: 28363599
    [Abstract] [Full Text] [Related]

  • 7. Facile strategy by hyaluronic acid functional carbon dot-doxorubicin nanoparticles for CD44 targeted drug delivery and enhanced breast cancer therapy.
    Li J, Li M, Tian L, Qiu Y, Yu Q, Wang X, Guo R, He Q.
    Int J Pharm; 2020 Mar 30; 578():119122. PubMed ID: 32035259
    [Abstract] [Full Text] [Related]

  • 8. Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin.
    Zhang J, Sun Y, Tian B, Li K, Wang L, Liang Y, Han J.
    Colloids Surf B Biointerfaces; 2016 Aug 01; 144():293-302. PubMed ID: 27107383
    [Abstract] [Full Text] [Related]

  • 9. Hyaluronic acid oligosaccharide modified redox-responsive mesoporous silica nanoparticles for targeted drug delivery.
    Zhao Q, Geng H, Wang Y, Gao Y, Huang J, Wang Y, Zhang J, Wang S.
    ACS Appl Mater Interfaces; 2014 Nov 26; 6(22):20290-9. PubMed ID: 25311422
    [Abstract] [Full Text] [Related]

  • 10. Hyaluronic acid-modified mesoporous silica-coated superparamagnetic Fe3O4 nanoparticles for targeted drug delivery.
    Fang Z, Li X, Xu Z, Du F, Wang W, Shi R, Gao D.
    Int J Nanomedicine; 2019 Nov 26; 14():5785-5797. PubMed ID: 31440047
    [Abstract] [Full Text] [Related]

  • 11. Hyaluronic acid ion-pairing nanoparticles for targeted tumor therapy.
    Li W, Yi X, Liu X, Zhang Z, Fu Y, Gong T.
    J Control Release; 2016 Mar 10; 225():170-82. PubMed ID: 26826304
    [Abstract] [Full Text] [Related]

  • 12. Stealth CD44-targeted hyaluronic acid supramolecular nanoassemblies for doxorubicin delivery: probing the effect of uncovalent pegylation degree on cellular uptake and blood long circulation.
    Han X, Li Z, Sun J, Luo C, Li L, Liu Y, Du Y, Qiu S, Ai X, Wu C, Lian H, He Z.
    J Control Release; 2015 Jan 10; 197():29-40. PubMed ID: 25449802
    [Abstract] [Full Text] [Related]

  • 13. Dual targeting mesoporous silica nanoparticles for inhibiting tumour cell invasion and metastasis.
    Li W, Guo Z, Zheng K, Ma K, Cui C, Wang L, Yuan Y, Tang Y.
    Int J Pharm; 2017 Dec 20; 534(1-2):71-80. PubMed ID: 28958879
    [Abstract] [Full Text] [Related]

  • 14. Self-assembled pH-responsive hyaluronic acid-g-poly((L)-histidine) copolymer micelles for targeted intracellular delivery of doxorubicin.
    Qiu L, Li Z, Qiao M, Long M, Wang M, Zhang X, Tian C, Chen D.
    Acta Biomater; 2014 May 20; 10(5):2024-35. PubMed ID: 24365705
    [Abstract] [Full Text] [Related]

  • 15. Construction of a tumor microenvironment pH-responsive cleavable PEGylated hyaluronic acid nano-drug delivery system for colorectal cancer treatment.
    Zhang X, Zhao M, Cao N, Qin W, Zhao M, Wu J, Lin D.
    Biomater Sci; 2020 Mar 31; 8(7):1885-1896. PubMed ID: 32022813
    [Abstract] [Full Text] [Related]

  • 16. Hyaluronic acid-nimesulide conjugates as anticancer drugs against CD44-overexpressing HT-29 colorectal cancer in vitro and in vivo.
    Jian YS, Chen CW, Lin CA, Yu HP, Lin HY, Liao MY, Wu SH, Lin YF, Lai PS.
    Int J Nanomedicine; 2017 Mar 31; 12():2315-2333. PubMed ID: 28392690
    [Abstract] [Full Text] [Related]

  • 17. Hepatocellular carcinoma dually-targeted nanoparticles for reduction triggered intracellular delivery of doxorubicin.
    Mezghrani O, Tang Y, Ke X, Chen Y, Hu D, Tu J, Zhao L, Bourkaib N.
    Int J Pharm; 2015 Jan 30; 478(2):553-68. PubMed ID: 25455765
    [Abstract] [Full Text] [Related]

  • 18. Surface Engineered Protein Nanoparticles With Hyaluronic Acid Based Multilayers For Targeted Delivery Of Anticancer Agents.
    Pulakkat S, Balaji SA, Rangarajan A, Raichur AM.
    ACS Appl Mater Interfaces; 2016 Sep 14; 8(36):23437-49. PubMed ID: 27560126
    [Abstract] [Full Text] [Related]

  • 19. Photochemically triggered cytosolic drug delivery using pH-responsive hyaluronic acid nanoparticles for light-induced cancer therapy.
    Lee CS, Na K.
    Biomacromolecules; 2014 Nov 10; 15(11):4228-38. PubMed ID: 25251731
    [Abstract] [Full Text] [Related]

  • 20. Tumor microenvironment dual-responsive core-shell nanoparticles with hyaluronic acid-shield for efficient co-delivery of doxorubicin and plasmid DNA.
    Wang T, Yu X, Han L, Liu T, Liu Y, Zhang N.
    Int J Nanomedicine; 2017 Nov 10; 12():4773-4788. PubMed ID: 28740384
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.